Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects

NCT00837356 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A

Interventions

DRUG: Advate®
DRUG: turoctocog alfa

Sponsor

Novo Nordisk A/S